AN2 Therapeutics ANTX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.14 | 106.96 | -0.28 | -9,316 | -9 | |
| 2025Q3 | 1.27 | 107.35 | -0.31 | -10,040 | -9 | |
| 2025Q2 | 1.06 | 111.67 | -0.22 | -7,216 | -6 | |
| 2025Q1 | 1.36 | 108.34 | -0.35 | -11,537 | -11 | |
| 2024Q4 | 1.38 | 114.30 | -0.25 | -8,598 | -8 | |
| 2024Q3 | 1.07 | 109.94 | -0.43 | -14,014 | -13 | |
| 2024Q2 | 2.15 | 110.01 | -0.48 | -15,880 | -14 | |
| 2024Q1 | 3.25 | 110.10 | -0.56 | -18,296 | -17 | |
| 2023Q4 | 20.49 | 111.34 | -0.52 | -18,815 | -17 | |
| 2023Q3 | 16.08 | 108.82 | -0.62 | -18,180 | -17 | |
| 2023Q2 | 8.50 | 105.04 | -0.81 | -16,601 | -16 | |
| 2023Q1 | 9.87 | 104.67 | -0.79 | -16,039 | -15 | |
| 2022Q4 | 9.53 | 105.35 | -0.58 | -12,476 | -12 | |
| 2022Q3 | 17.38 | 103.80 | -0.47 | -11,770 | -11 | |
| 2022Q2 | 7.75 | 102.10 | 1.24 | -10,333 | -10 | |
| 2022Q1 | 15.07 | 100.37 | -2.98 | -7,683 | -8 | |
| 2021Q4 | -7,594 | -8 | ||||
| 2021Q3 | -0.63 | -6,932 | -7 | |||
| 2021Q2 | -0.49 | -4,998 | -5 | |||
| 2021Q1 | -0.20 | -2,050 | -2 |